A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)
Establishing Biobank in a Cohort Study for Hypertensive Patients in Guangdong Province(GDP Study)
1 other identifier
observational
50,000
1 country
2
Brief Summary
Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 24, 2019
CompletedFirst Posted
Study publicly available on registry
December 27, 2019
CompletedStudy Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2050
ExpectedJanuary 13, 2020
December 1, 2019
3 years
December 24, 2019
January 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
All-Cause Mortality
All-cause mortality was confirmed through a combination of hospital medical records, telephone contacts with patients or family members, and death registration at the Guangdong Provincial Center for Disease Control and Prevention.
From date of inclusion until the date of death from any cause, assessed up to 1 year
Secondary Outcomes (1)
Cardiovascular Mortality
From date of inclusion until the date of death from any cause, assessed up to 1 year
Other Outcomes (4)
Secondary outcomes of cardiovascular diseases
Through study completion, an average of 1 years
Secondary outcomes of cerebrovascular diseases
Through study completion, an average of 1 years
Secondary outcomes of kidney
Through study completion, an average of 1 years
- +1 more other outcomes
Interventions
This is an observational, non-interventional study
Eligibility Criteria
Patients with hypertension
You may qualify if:
- ≥18 years old
- In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension)
You may not qualify if:
- \<18 years old
- Unsigned informed consent
- Pregnant Women and Lactation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, 510080, China
Guangdong Cardiovascular Institute
Guangzhou, Guangdong, 510100, China
Biospecimen
This study will collect 20 mL whole blood samples from subjects at one or more study visits. The whole blood will be processed to plasma and stored for testing
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Feng Ying-qing, PhD
Guangdong Provincial People's Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 24, 2019
First Posted
December 27, 2019
Study Start
January 1, 2020
Primary Completion
December 31, 2022
Study Completion (Estimated)
December 31, 2050
Last Updated
January 13, 2020
Record last verified: 2019-12
Data Sharing
- IPD Sharing
- Will not share